Symposia: Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Acute Myeloid Malignancies, AML, APL, Clinical Research, Diseases, Myeloid Malignancies
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Acute Myeloid Malignancies, AML, APL, Clinical Research, Diseases, Myeloid Malignancies
Saturday, December 9, 2023: 2:00 PM-3:30 PM
Room 6A
(San Diego Convention Center)
Moderators:
Jacob S. Appelbaum, MD, PhD, Fhcrc/Seattle Cancer Care Alliance
and
Catherine Lai, MD, University of Pennsylvania
Disclosures:
Lai: AbbVie: Consultancy; Astellas: Consultancy; Rigel: Consultancy; BMS: Consultancy; Genentech: Consultancy; Novartis: Consultancy; Daiichi: Consultancy; Taiho: Consultancy; Pfizer: Consultancy; Jazz: Consultancy, Research Funding.
This session includes combinations of drugs that are currently FDA approved and are being used in dosing and combinations that have not been tried before with good outcomes.
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH